TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29073608

Group type: EXPERIMENTAL
Intervention: 10 h of computerized, specific neuropsychological training performing simple reaction time tasks (Intervention Group, n = 14)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Computerized, unspecific neuropsychological training using tasks without time components (Control Group, n = 16)
Number of subjects: 30
Study: 25847553

Group type: EXPERIMENTAL
Intervention: Test formulation group (TFG) - received two 500mg capsules of test formulation daily for 3 months
Number of subjects: 130
Study: 23361504

Group type: EXPERIMENTAL
Intervention: Ortho-k lenses
Number of subjects: 76

Group type: COMPARATOR
Intervention: Single-vision spectacles
Number of subjects: 76
Study: 21558566

Group type: EXPERIMENTAL
Intervention: High-calorie-expenditure (HCE) exercise (3,000-3,500 kcal/wk daily walking)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard cardiac-rehabilitation (CR) exercise (700-800 kcal/wk)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: High-calorie-expenditure (HCE) exercise
Number of subjects: 74
Study: 20877184

Group type: EXPERIMENTAL
Intervention: Systemic hypothermia (n = 46), induced within 10 hours after birth, decreasing rectal temperature to 33.5°C for 72 hours
Number of subjects: 93

Group type: COMPARATOR
Intervention: Conventional treatment (n = 47)
Number of subjects: 93
Study: 17060277

Group type: EXPERIMENTAL
Intervention: 8-session, structured, multidisciplinary intervention
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 103
Study: 15342617

Group type: EXPERIMENTAL
Intervention: Frovatriptan 2.5 mg oral dose
Number of subjects: 25
Study: 10843823

Group type: EXPERIMENTAL
Intervention: Diagnosed myocardial infarction
Number of subjects: 7735

Group type: EXPERIMENTAL
Intervention: Unrecognized myocardial infarction
Number of subjects: 7735

Group type: EXPERIMENTAL
Intervention: Diagnosed angina
Number of subjects: 7735

Group type: EXPERIMENTAL
Intervention: Angina symptoms
Number of subjects: 7735

Group type: EXPERIMENTAL
Intervention: Possible myocardial infarction symptoms
Number of subjects: 7735

Group type: EXPERIMENTAL
Intervention: ECG ischaemia
Number of subjects: 7735

Group type: EXPERIMENTAL
Intervention: No evidence of ischaemic heart disease
Number of subjects: 7735
Study: 9088589

Group type: EXPERIMENTAL
Intervention: GR117289C 10 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GR117289C 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GR117289C 300 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8227803

Group type: EXPERIMENTAL
Intervention: Immediate release nifedipine therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo period
Number of subjects: 30
Study: 3100446

Group type: EXPERIMENTAL
Intervention: 60 mg/kg BW carnitine daily as a continuous infusion over 16 h
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no carnitine)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 60 mg/kg BW carnitine daily
Number of subjects: 24
Study: 3259521

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy with polidocanol 1%
Number of subjects: 55

Group type: COMPARATOR
Intervention: Oral propranolol (average daily dose 160 mg)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Oral propranolol
Number of subjects: 55
Study: 31805052

Group type: EXPERIMENTAL
Intervention: Intralesional meglumine antimoniate therapy (IL‐MA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endovenous meglumine antimoniate therapy (EV‐MA)
Number of subjects: 0
Study: 27984231

Group type: EXPERIMENTAL
Intervention: Cycled lighting
Number of subjects: 38

Group type: COMPARATOR
Intervention: Continuous near darkness
Number of subjects: 38
Study: 25863828

Group type: EXPERIMENTAL
Intervention: 6-times-weekly home nocturnal hemodialysis
Number of subjects: 87

Group type: COMPARATOR
Intervention: 3-times-weekly hemodialysis (conventional arm)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: 6-month running treatment data analysis
Number of subjects: 87
Study: 23436910

Group type: EXPERIMENTAL
Intervention: Therapist-delivered acupuncture
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Self-acupuncture/self-needling
Number of subjects: 197

Group type: COMPARATOR
Intervention: No further acupuncture (control)
Number of subjects: 197
Study: 21425723

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 19429874

Group type: COMPARATOR
Intervention: Subcutaneous insulin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CIPII (Continuous Intraperitoneal Insulin Infusion)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CIPII
Number of subjects: 24
Study: 16566624

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 52
Study: 14694037

Group type: EXPERIMENTAL
Intervention: Patients with T2-weighted MRI hyperintensities (T2H), n = 58
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients with normal MRI
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients with T2H
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 100
Study: 11314354

Group type: EXPERIMENTAL
Intervention: Prophylaxis only
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Sable seek caries detector dye
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Chlorhexidine cavity cleanser
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Caries detector dye followed by prophylaxis
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Cavity cleanser followed by caries detector dye
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Snoop caries detector dye
Number of subjects: 108
Study: 9059294

Group type: COMPARATOR
Intervention: Doppler ultrasound (US)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Dynamic contrast enhanced MRI (DCEMR)
Number of subjects: 97
Study: 8403111

Group type: EXPERIMENTAL
Intervention: Desflurane (DF)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Isoflurane (IF)
Number of subjects: 48
Study: 3803413

Group type: EXPERIMENTAL
Intervention: Pinacidil (62 +/- 18 mg/day)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Hydralazine (128 +/- 28 mg/day)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Pinacidil
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 43
Study: 30181085

Group type: COMPARATOR
Intervention: 0.9% Normal Saline (NS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isolyte
Number of subjects: 30
Study: 28514309

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) 200 U subcutaneous injection, once daily at the painful area
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 44
Study: 25464446

Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training (AIT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Aerobic Continuous Training (ACT)
Number of subjects: 200
Study: 24335762

Group type: EXPERIMENTAL
Intervention: 554 kcal mixed meal
Number of subjects: 24

Group type: COMPARATOR
Intervention: 50 ml water
Number of subjects: 24
Study: 21590446

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (PLD)
Number of subjects: 70
Study: 19774841

Group type: EXPERIMENTAL
Intervention: Kung Fu training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tai Chi (placebo)
Number of subjects: 20
Study: 17469765

Group type: EXPERIMENTAL
Intervention: 330 ml beer per day for 30 consecutive days (EG)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 42
Study: 15206999

Group type: EXPERIMENTAL
Intervention: Iohexol contrast medium
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (not taking amiodarone or QT-prolonging drugs)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Iohexol contrast medium with amiodarone
Number of subjects: 21
Study: 12228873

Group type: EXPERIMENTAL
Intervention: Hormonal treatments
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (Close monitoring)
Number of subjects: 65
Study: 9707042

Group type: EXPERIMENTAL
Intervention: Triple therapy with ranitidine bismuth citrate (RBC) 400 mg b.i.d., clarithromycin 500 mg b.i.d., and metronidazole 500 mg b.i.d.
Number of subjects: 104

Group type: COMPARATOR
Intervention: Dual therapy with ranitidine bismuth citrate (RBC) 400 mg b.i.d. and clarithromycin 500 mg b.i.d.
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both triple and dual therapy
Number of subjects: 104
Study: 7793859

Group type: EXPERIMENTAL
Intervention: Atevirdine mesylate (400 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Atevirdine mesylate (800 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Atevirdine mesylate (1,200 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Atevirdine mesylate (1,600 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Atevirdine mesylate (all doses)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2307239

Group type: COMPARATOR
Intervention: FAM chemotherapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: FAM chemotherapy plus aminoglutethimide/hydrocortisone (AG/HC) (250 mg bid AG + 20 mg bid HC)
Number of subjects: 28
Study: 86727

Group type: COMPARATOR
Intervention: Outpatient care
Number of subjects: 106

Group type: COMPARATOR
Intervention: Psychiatric day care
Number of subjects: 106
Study: 31772102

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 2090

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2090
Study: 27840336

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 7875

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg daily
Number of subjects: 7875
Study: 25557371

Group type: EXPERIMENTAL
Intervention: DMF 240 mg BID
Number of subjects: 2301

Group type: EXPERIMENTAL
Intervention: DMF 240 mg TID
Number of subjects: 2301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2301
Study: 24345717

Group type: EXPERIMENTAL
Intervention: Venlafaxine extended release (ER) (75-300 mg/d)
Number of subjects: 1047

Group type: COMPARATOR
Intervention: Fluoxetine (20-60 mg/d)
Number of subjects: 1047
Study: 21537042

Group type: EXPERIMENTAL
Intervention: Goserelin (3.6 mg subcutaneously every 4 weeks until the end of the last cycle)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chemotherapy alone (anthracycline/cyclophosphamide with or without taxane)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Goserelin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 60
Study: 19726376

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 60
Study: 17711042

Group type: EXPERIMENTAL
Intervention: Acupuncture (local points)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acupuncture (distant points)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acupuncture (local and distant points)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Long-distance acupuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Rest Position)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Bilateral Molar Clenching with Cotton Rolls)
Number of subjects: 30
Study: 14756851

Group type: EXPERIMENTAL
Intervention: Diclofenac softgel 100 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Diclofenac softgel 100 mg plus caffeine 100 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 11478553

Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cefotiam
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ampicillin/Sulbactam
Number of subjects: 40
Study: 10030097

Group type: EXPERIMENTAL
Intervention: Classical pharmacological treatments (diuretics and beta blockers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New drugs (calcium antagonists and angiotensin converting enzyme inhibitors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non pharmacological therapies (sodium restriction, weight reduction, avoidance of alcohol intake, calcium and potassium supplementation)
Number of subjects: 0
Study: 8047525

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine system 7 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine system 14 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine system 21 mg per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-abstinent patients
Number of subjects: 0
Study: 2647360

Group type: EXPERIMENTAL
Intervention: Immediate post-operative radiotherapy
Number of subjects: 1461

Group type: COMPARATOR
Intervention: Delayed radiotherapy on recurrence (watched group)
Number of subjects: 1461
Study: 31311361

Group type: EXPERIMENTAL
Intervention: Asthma question prompt list/video intervention
Number of subjects: 359

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Control medication at baseline
Number of subjects: 359
Study: 30862052

Group type: EXPERIMENTAL
Intervention: Text messaging intervention linked to an activity monitor, adaptive physical activity goal setting, and limited face-to-face counseling
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 28820156

Group type: EXPERIMENTAL
Intervention: Viscoelastic‐augmented trabeculectomy (VAT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional trabeculectomy (CT)
Number of subjects: 65
Study: 26422235

Group type: EXPERIMENTAL
Intervention: Complex intervention (training clinicians in health risk screening, motivational interviewing, and engaging youth)
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: Complex intervention
Number of subjects: 901

Group type: COMPARATOR
Intervention: Comparison (didactic educational seminar)
Number of subjects: 901
Study: 24725024

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: IVIG
Number of subjects: 44
Study: 22072950

Group type: EXPERIMENTAL
Intervention: Habitual n-3 PUFA intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adipogenic transcription factors
Number of subjects: 0
Study: 19371202

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 0
Study: 17011359

Group type: EXPERIMENTAL
Intervention: Bioenergetic exercises (BE)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Gymnastic exercises (Control)
Number of subjects: 128
Study: 15332570

Group type: EXPERIMENTAL
Intervention: Stenting of the basic and side branch of the coronary artery (Group 1, n = 27)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Stenting of the basic branch and balloon angioplasty of the side branch (Group 2, n = 29)
Number of subjects: 56
Study: 11057350

Group type: EXPERIMENTAL
Intervention: Emedastine 0.05% ophthalmic solution BID
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levocabastine 0.05% ophthalmic suspension BID
Number of subjects: 0
Study: 9278077

Group type: EXPERIMENTAL
Intervention: Posterolateral arthrodesis with instrumentation and decompression
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Posterolateral arthrodesis with instrumentation without decompression
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Posterolateral arthrodesis without instrumentation and decompression
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Posterolateral arthrodesis without instrumentation without decompression
Number of subjects: 42
Study: 7865685

Group type: EXPERIMENTAL
Intervention: t-PA antigen in FH patients at rest
Number of subjects: 14

Group type: COMPARATOR
Intervention: t-PA antigen in normolipaemic controls (NLC) at rest
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: t-PA antigen after bicycle exercise in both groups
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: t-PA activity in FH patients during exercise
Number of subjects: 14

Group type: COMPARATOR
Intervention: t-PA activity in NLC during exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Thrombin-antithrombin III complex (TAT) at rest and after exercise
Number of subjects: 14
Study: 2669629

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (2-day course)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Doxycycline (2-day course)
Number of subjects: 43
Study: 401589

Group type: EXPERIMENTAL
Intervention: Magnesium citrate and bisacodyl
Number of subjects: 500

Group type: COMPARATOR
Intervention: Castor oil followed by phosphate enema
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Calcium bisdiocytl sulfosuccinate with magnesium citrate and bisacodyl
Number of subjects: 500
Study: 31784483

Group type: EXPERIMENTAL
Intervention: Simulated trial arms with genetic variance
Number of subjects: 5851

Group type: EXPERIMENTAL
Intervention: GBA gene-only simulations
Number of subjects: 5851

Group type: EXPERIMENTAL
Intervention: Drug effect of -0.5 points in MDS-UPDRS per year
Number of subjects: 5851
Study: 30832955

Group type: EXPERIMENTAL
Intervention: Vermont Family Based Approach (VFBA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 28137734

Group type: EXPERIMENTAL
Intervention: Thyroxine treatment
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 27622699

Group type: EXPERIMENTAL
Intervention: Fluticasone Furoate (FF) 25 µg once daily
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Fluticasone Furoate (FF) 50 µg once daily
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Fluticasone Furoate (FF) 100 µg once daily
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Fluticasone Propionate (FP) 100 µg twice daily
Number of subjects: 593

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Fluticasone Furoate (FF) groups
Number of subjects: 593
Study: 23739219

Group type: EXPERIMENTAL
Intervention: Misoprostol 400 µg vaginally 4 hours prior to IUD insertion
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study: 21104041

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (1-hour sessions, 36 sessions over 12 weeks)
Number of subjects: 21
Study: 19503006

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 20 mg
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 40 mg
Number of subjects: 444

Group type: COMPARATOR
Intervention: Raloxifene 60 mg
Number of subjects: 444

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 444
Study: 17126767

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CHO diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: SFA diet
Number of subjects: 20
Study: 14660300

Group type: EXPERIMENTAL
Intervention: Epoetin-alpha (150 U/kg or 250 U/kg, thrice weekly for 12 weeks)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Epoetin-alpha (150 U/kg)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Epoetin-alpha (250 U/kg)
Number of subjects: 41
Study: 11451296

Group type: EXPERIMENTAL
Intervention: Pravastatin treatment
Number of subjects: 8557

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8557
Study: 8918495

Group type: EXPERIMENTAL
Intervention: sargramostim (GM-CSF) 250 micrograms/m2/d SC on days 3 through 15
Number of subjects: 142

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: sargramostim (GM-CSF)
Number of subjects: 142
Study: 1757605

Group type: EXPERIMENTAL
Intervention: 0.05% halobetasol propionate ointment
Number of subjects: 134

Group type: COMPARATOR
Intervention: 0.05% clobetasol propionate ointment
Number of subjects: 134
Study: 6810904

Group type: EXPERIMENTAL
Intervention: bezafibrate
Number of subjects: 16
Study: 30869956

Group type: EXPERIMENTAL
Intervention: Response scales with 2 to 5 options
Number of subjects: 1358

Group type: EXPERIMENTAL
Intervention: Response scales with more than 6 options
Number of subjects: 1358

Group type: EXPERIMENTAL
Intervention: Visual analog condition
Number of subjects: 1358

Group type: EXPERIMENTAL
Intervention: Criterion validity results
Number of subjects: 1358
Study: 27593901

Group type: EXPERIMENTAL
Intervention: Experimental_1 group
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Experimental_2 group
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 230
Study: 25519197

Group type: EXPERIMENTAL
Intervention: High-dose probiotics (10^10 cells for 21 days)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Standard-dose probiotics (10^10 cells for 14 days)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Lower-dose probiotics (10^9 cells for 21 days)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 24378016

Group type: EXPERIMENTAL
Intervention: 4g/day prescription omega‐3 fatty acid ethyl ester (P‐OM3)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Combination therapy (P‐OM3 + ERN)
Number of subjects: 61

Group type: COMPARATOR
Intervention: 2g/day extended‐release nicotinic acid (ERN)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 21699447

Group type: EXPERIMENTAL
Intervention: Electronic salt sensor and personalized e-mail advice
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (counseled together with intervention group)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 41
Study: 19216960

Group type: EXPERIMENTAL
Intervention: 40 mm Hg nongraduated sustained pneumatic compression (SPC) for 6 hours
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 60 mm Hg graduated intermittent pneumatic compression (IPC) for 2 hours
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 30 to 40 mm Hg graduated SPC for 6 hours
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 50 mm Hg graduated IPC for 2 hours
Number of subjects: 28

Group type: COMPARATOR
Intervention: Baseline profile with no compression
Number of subjects: 28